Effect of Left Ventricular Assist Device Infection on Post-transplant Outcomes

被引:61
|
作者
Schulman, Allison R. [1 ]
Martens, Timothy P. [1 ]
Russo, Mark J. [1 ]
Christos, Paul J. [2 ]
Gordon, Rachel J. [1 ]
Lowy, Franklin D. [1 ]
Oz, Mehmet C. [1 ]
Naka, Yoshifumi [1 ]
机构
[1] Columbia Univ, Med Ctr, Div Cardiothorac Surg, New York, NY 10032 USA
[2] Cornell Univ, Weill Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY 10021 USA
关键词
IMPLANTATION; SUPPORT; HYPOGAMMAGLOBULINEMIA; TRANSPLANTATION; PREVENTION; EXPERIENCE; MANAGEMENT; SURFACE; BRIDGE; IMPACT;
D O I
10.1016/j.healun.2008.12.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: in this study, we sought to confirm which types of device-related infections impact bridge-to-transplant rates. We also aimed to determine the effect of device-related infections on post-transplant survival and post-transplant infection. Methods: We retrospectively reviewed paper and electronic medical records for 149 patients undergoing left ventricular assist device (LVAD) implantation as a bridge to transplantation at the Columbia Presbyterian Medical Center between 2000 and 2006. The primary outcome measures were survival to transplantation, post-transplant infection and post-transplant survival. Results: Patients with sepsis were less likely to be successfully bridged to cardiac transplantation (7 of 22 vs 103 of 127, 31.8% vs 81.1%, p = 0.01). However, if transplanted, their survival rates at 1 year were not decreased (6 of 7 vs 85 of 103, 85.7% vs 82.5%, p = 1.00). No other pre-transplant device-related infection affected post-transplant survival at 1 year (22 of 27 vs 69 of 83, 81.5% vs 83.1%, P = 1.00). Pre-transplant drive-fine infections predicted post-transplant: infection in former drive-line or pocket sites (11 of 16 vs 14 of 94, 68.8% vs 14.9%, p = 0.01) and increased overall post-transplant hospital length of stay (16 vs 19 days, p = 0.04). They did not, however, affect post-transplant survival at I year (22 of 25 vs 69 of 85, 88% vs 81.2%, p = 0.56). Conclusions: Although survival to transplantation was diminished in LVAD patients with sepsis, if successfully transplanted, post-transplant survival was unaffected. Patients with local device infections and signs of early sepsis may warrant evaluation for urgent transplantation. A pre-transplant drive-line infection was associated with post-transplant infection in either the former pocket or drive-line site, and increased overall length of stay, but it did not decrease post-transplant survival. J Heart Lung Transplant 2009;28:237-42. Copyright (C) 2009 by the International Society for Heart and Lung Transplantation.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 50 条
  • [21] Blood stream infection and outcomes in recipients of a left ventricular assist device
    Angleitner, Philipp
    Matic, Aleksa
    Kaider, Alexandra
    Dimitrov, Kamen
    Sandner, Sigrid
    Wiedemann, Dominik
    Riebandt, Julia
    Schloglhofer, Thomas
    Laufer, Guenther
    Zimpfer, Daniel
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (05) : 907 - 914
  • [22] Inpatient Rehabilitation Outcomes for Patients Receiving Left Ventricular Assist Device
    Alsara, Osama
    Reeves, Ronald K.
    Pyfferoen, Mary D.
    Trenary, Tamra L.
    Engen, Deborah J.
    Vitse, Merri L.
    Kessler, Stacy M.
    Kushwaha, Sudhir S.
    Clavell, Alfredo L.
    Thomas, Randal J.
    Lopez-Jimenez, Francisco
    Park, Soon J.
    Perez-Terzic, Carmen M.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2014, 93 (10) : 860 - 868
  • [23] Outcomes Following Left Ventricular Assist Device Exchange: Focus on the Impacts of Device Infection
    Yost, Gardner
    Coyle, Laura
    Gallagher, Colleen
    Cotts, William
    Pappas, Patroklos
    Tatooles, Antone
    ASAIO JOURNAL, 2021, 67 (06) : 642 - 649
  • [24] Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices
    Ventura, Pere A.
    Alharethi, Rami
    Budge, Deborah
    Reid, Bruce B.
    Horne, Benjamin D.
    Mason, Nathan O.
    Stoker, Sandi
    Caine, William T.
    Rasmusson, Brad
    Doty, John
    Clayson, Stephen E.
    Kfoury, Abdallah G.
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : E390 - E395
  • [25] Risk of left ventricular assist device driveline infection: A systematic literature review
    Pavlovic, Noelle, V
    Randell, Tania
    Madeira, Tim
    Hsu, Steven
    Zinoviev, Radoslav
    Abshire, Martha
    HEART & LUNG, 2019, 48 (02): : 90 - 104
  • [26] Outcomes after stroke complicating left ventricular assist device
    Willey, Joshua Z.
    Gavalas, Michael. V.
    Trinh, Pauline N.
    Yuzefpolskaya, Melana
    Garan, A. Reshad
    Levin, Allison P.
    Takeda, Koji
    Takayama, Hiroo
    Fried, Justin
    Naka, Yoshifumi
    Topkara, Veli K.
    Colombo, Paolo C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (08) : 1003 - 1009
  • [27] Outcomes of left ventricular assist device implantation in hypercoagulable patients
    Dufendach, Keith A.
    Seese, Laura
    Stearns, Blaise
    Hickey, Gavin
    Mathier, Michael
    Keebler, Mary
    Chen, Shangzhen
    Sciortino, Christopher M.
    Thoma, Floyd W.
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (09) : 2201 - 2207
  • [28] The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review
    Lerman, Dana T.
    Hamilton, Keith W.
    Byrne, Dana
    Lee, Doreen F.
    Zeitler, Kristen
    Claridge, Tamara
    Gray, Jaime
    Minamoto, Grace Y.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (06)
  • [29] The Effect of Continuous-Flow Left Ventricular Assist Device Duration on Postoperative Outcomes
    Chauhan, Dhaval
    Okoh, Alexis K.
    Haik, Nicky
    Kang, Nathan
    Choi, Michael
    Baran, David
    Zucker, Mark
    Camacho, Magarita
    Russo, Mark J.
    ANNALS OF THORACIC SURGERY, 2017, 104 (06) : 1933 - 1938
  • [30] Left Ventricular Assist Device in Older Adults
    Caraang, Chris
    Lanier, Gregg M.
    Gass, Alan
    Aronow, Wilbert S.
    Gupta, Chhaya Aggarwal
    HEART FAILURE CLINICS, 2017, 13 (03) : 619 - +